about
Rotavirus-specific T cell responses and cytokine mRNA expression in children with diabetes-associated autoantibodies and type 1 diabetesPredominant occupation of the class I MHC molecule H-2Kwm7 with a single self-peptide suggests a mechanism for its diabetes-protective effect.B cells and type 1 diabetes ...in mice and men.Quantification and three-dimensional imaging of the insulitis-induced destruction of beta-cells in murine type 1 diabetesα1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1β responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes.TGF-beta signaling is required for the function of insulin-reactive T regulatory cellsZnT8-Specific CD4+ T cells display distinct cytokine expression profiles between type 1 diabetes patients and healthy adultsThymus-specific deletion of insulin induces autoimmune diabetes.Histone deacetylase inhibitor suppresses virus-induced proinflammatory responses and type 1 diabetes.Modulation of virus-induced innate immunity and type 1 diabetes by IL-1 blockade.Contribution of antibodies against IA-2β and zinc transporter 8 to classification of diabetes diagnosed under 40 years of age.Bioengineered stem cells as an alternative for islet cell transplantation.C-peptide response and HLA genotypes in subjects with recent-onset type 1 diabetes after immunotherapy with DiaPep277: an exploratory studyAlterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 DiabetesInsulin transactivator MafA regulates intrathymic expression of insulin and affects susceptibility to type 1 diabetes.Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD miceDysregulated Toll-like receptor-induced interleukin-1β and interleukin-6 responses in subjects at risk for the development of type 1 diabetesImplication of the intestinal microbiome as a potential surrogate marker of immune responsiveness to experimental therapies in autoimmune diabetes.Immunotherapy for the prevention and treatment of type 1 diabetes.Relapsing and remitting severe hypoglycemia due to a monoclonal anti-insulin antibody heralding a case of multiple myelomaImmunosuppression in islet transplantationSelective delivery of beta cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice.B-cell depletion with rituximab in the treatment of autoimmune diseases. Graves' ophthalmopathy the latest addition to an expanding family.New potential treatments for protection of pancreatic B-cell function in Type 1 diabetes.Teplizumab therapy for type 1 diabetes.The immunotherapeutic potential of dendritic cells in type 1 diabetes.Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes.Dendritic cell therapy for Type 1 diabetes suppression.The Role of the Intestinal Microbiome in Type 1 Diabetes Pathogenesis.Inhibition of GSK3 promotes replication and survival of pancreatic beta cells.β-cell preservation and regeneration for diabetes treatment: where are we now?CD40 is required for development of islet inflammation in the RIP-CD154 transgenic mouse model of type 1 diabetes.Emergence of a Broad Repertoire of GAD65-Specific T-Cells in Type 1 Diabetes Patients with Graft Dysfunction after Allogeneic Islet Transplantation
P2860
Q24683918-DF720116-07DD-4415-8BC2-0E23FADB69E9Q27659105-FE5E365A-769C-47FA-9D6D-0DE483763238Q33926306-20E9C3AD-2B2C-4D34-828B-8D32286A406EQ33930292-E2354BD4-CE2C-41CA-9722-91EC445D3E4FQ33999020-6818A0B7-249B-40FD-B361-A1034CFAAF5EQ34576601-4ED30097-AE85-4423-A824-01CD000195A5Q34580119-F624E38C-F1E1-4752-9C7A-F2DEC136C585Q34610806-834953FF-193A-4196-9FA6-32B4CB44E536Q34975260-F5BCE842-64CD-440C-A5E7-820D9D56429EQ34996033-ED66D687-53B8-4514-B603-7033D2B77770Q35123421-4627F974-80B7-4C69-B883-C86A25C284BDQ35210721-916F9DC5-0D1B-4A86-A692-3283D7C55678Q35404985-CE57D0F4-A556-4FD7-91A6-C58D0EBA717CQ35661927-55A1E8C8-580F-47CA-A21E-779A27BB3DE4Q35757146-36E1AAFB-4F9F-4F10-9E70-17FB5957A93CQ36228938-EACE5913-8B4C-441F-9910-2CB28358FA37Q36249702-33D98588-D3AE-4032-9083-DA39CCBC8472Q36310672-3173CB40-7B69-44CC-9344-CA465A6046A3Q36327355-ED97B097-47B4-496D-B313-584302D0A76DQ36442441-1DE26F04-429D-432B-B6DB-79CFC8957ED8Q36570514-F8BBC0A8-EA4D-4345-A9AE-DCBF1BA597FEQ36609044-8874F330-D0AC-4559-B5BF-51F0DBBAEAC2Q36897408-8F680DDE-21BA-4226-8ABD-97961CF96B7BQ37240506-95099AEC-8F81-4466-A960-CA848D25A823Q37679927-1CF5B16C-83A1-4E39-A164-0F9705F1A95BQ37759033-A5E1C358-60FA-459C-BDEF-108E0424A1DAQ37883029-8A6D1263-01AD-406E-85A8-A688BF1F9DEFQ38059518-6B8BD899-D82B-48CE-B1E2-B426FDE5756AQ38927461-50A85B4F-A66C-4D44-BF78-709F7DADAE16Q40180167-D4C641C7-681E-46DA-92C8-E9FDC274C030Q42535316-E89057D8-4D06-428A-8DFC-30B737D70555Q53563234-BDBCDD4D-D619-48D6-9D3C-DAABC8CA7ABAQ57158416-48122BE6-F69E-469B-A671-BDB433A02BB6
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The stages of type 1A diabetes: 2005.
@ast
The stages of type 1A diabetes: 2005.
@en
type
label
The stages of type 1A diabetes: 2005.
@ast
The stages of type 1A diabetes: 2005.
@en
prefLabel
The stages of type 1A diabetes: 2005.
@ast
The stages of type 1A diabetes: 2005.
@en
P2860
P1476
The stages of type 1A diabetes: 2005.
@en
P2093
George S Eisenbarth
Roberto Gianani
P2860
P304
P356
10.1111/J.0105-2896.2005.00248.X
P577
2005-04-01T00:00:00Z